Limits...
Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.

Stienlauf S, Yahalom V, Schwartz E, Shinar E, Segal G, Sidi Y - Emerging Infect. Dis. (2009)

Bottom Line: The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons.In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively.HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

View Article: PubMed Central - PubMed

Affiliation: Sheba Medical Center, Tel Hashomer, Israel. sshmuel@netvision.net.il

ABSTRACT
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

Show MeSH

Related in: MedlinePlus

Algorithm for identifying the geographic origin of Israeli blood donors.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2744246&req=5

Figure 1: Algorithm for identifying the geographic origin of Israeli blood donors.

Mentions: On the basis of virus transmission modes, we developed an algorithm for identifying the ethnic origin of both HTLV-1–positive and HTLV-1–negative blood donors (Figure 1). We considered infection to be acquired in Israel when the donor and both parents were born in Israel. We considered infection to be acquired outside Israel when the donor or 1 parent was born outside Israel. When the donor was born in Israel and the mother was born outside Israel, country of origin was considered the mother's country of birth. When the donor and the mother were born in Israel, but the father was born outside Israel, country of origin was considered the father’s country of birth. Detailed classification of geographic origin of blood donors (both HTLV-1 positive and HTLV-1 negative) is given in the Technical Appendix.


Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.

Stienlauf S, Yahalom V, Schwartz E, Shinar E, Segal G, Sidi Y - Emerging Infect. Dis. (2009)

Algorithm for identifying the geographic origin of Israeli blood donors.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2744246&req=5

Figure 1: Algorithm for identifying the geographic origin of Israeli blood donors.
Mentions: On the basis of virus transmission modes, we developed an algorithm for identifying the ethnic origin of both HTLV-1–positive and HTLV-1–negative blood donors (Figure 1). We considered infection to be acquired in Israel when the donor and both parents were born in Israel. We considered infection to be acquired outside Israel when the donor or 1 parent was born outside Israel. When the donor was born in Israel and the mother was born outside Israel, country of origin was considered the mother's country of birth. When the donor and the mother were born in Israel, but the father was born outside Israel, country of origin was considered the father’s country of birth. Detailed classification of geographic origin of blood donors (both HTLV-1 positive and HTLV-1 negative) is given in the Technical Appendix.

Bottom Line: The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons.In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively.HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

View Article: PubMed Central - PubMed

Affiliation: Sheba Medical Center, Tel Hashomer, Israel. sshmuel@netvision.net.il

ABSTRACT
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

Show MeSH
Related in: MedlinePlus